Welcome to our dedicated page for NUTRANOMICS news (Ticker: NNRX), a resource for investors and traders seeking the latest updates and insights on NUTRANOMICS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NUTRANOMICS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NUTRANOMICS's position in the market.
NutraNomics, Inc. (OTC PINK:NNRX) has formed a strategic alliance with RE Strategies LLC, enhancing its growth prospects in the cannabis sector. RE Strategies, with 35 years of experience in finance, will provide creative financing solutions and capital sourcing. This partnership facilitated NutraNomics' acquisition of The Plant, a cannabis product manufacturer. CEO Jonathan Bishop expresses confidence in their collaboration, emphasizing RE Strategies' role in achieving financial and growth objectives. NutraNomics aims for further growth through mergers and acquisitions with RE Strategies.
NutraNomics, Inc. (OTC PINK:NNRX) announces its strategic positioning for success in California's cannabis market despite illegal competition. The Plant, a subsidiary, implements a business model focusing on high-quality production and cost efficiency, offering nearly 500 cannabis-based products. By maintaining complete supply chain control, The Plant can ensure quality and competitive pricing. With advantages like zero-dollar manufacturing tax and skilled labor, the company is well-prepared for future growth, as highlighted by its strong sales performance over recent quarters.
NutraNomics, Inc. (OTC PINK:NNRX) reported record sales for October 2022, with new bookings reaching $777,709, marking the highest monthly sales in its history. The company added 4 new partners in September and 19 new logos in Q3, reinforcing its strategy to diversify its customer base. CEO Jonathan Bishop emphasized that the success of their customers directly influences their own success. The announcement follows a commitment to excellence in organic plant-based nutritional science and hints at future updates on sales production.
NutraNomics, Inc. (NNRX) announced a correction to its previous press release, revealing a 40% growth in new sales bookings for Q3 2022, revising earlier figures. The company reported a remarkable 109% year-over-year growth in new sales bookings for the nine months ended September 30, 2022, totaling $3.385 million. Management indicated ongoing interest in contract manufacturing and a robust sales pipeline, predicting continued sales growth into 2023. This positive trend reflects effective business strategies and market execution.
NutraNomics, Inc. (OTC PINK:NNRX) reported record-breaking new sales bookings of $1,434,865 for Q3 2022, marking a 29% increase from Q2's $1,022,729. The growth highlights the company's strong market positioning and commitment to quality in the organic plant-based nutritional sector. As part of its growth strategy, NutraNomics hired two direct sales professionals and contracted independent representatives to expand its Southern California market reach. Continued updates on sales performance are anticipated in the coming months.
NutraNomics, Inc. (OTC PINK:NNRX) announced on September 20, 2022, the successful retirement of $500,000 in debt, converting it to equity, while securing a $400,000 credit line to bolster its operational and production needs. CEO Jonathan Bishop emphasized the importance of balancing financial health with growth objectives. The new credit facility aims to support the increasing demand from NutraNomics' customer base. The company expresses commitment to ongoing financial optimization and anticipates further announcements regarding its financial health.
NutraNomics, Inc. (OTC PINK:NNRX) has announced a significant expansion of its distribution network into Northern California through its subsidiary, Greenbird Distribution. A new hub has been established in Dixon, CA, enhancing operational efficiency and enabling 48-hour customer fulfillment. This expansion has already added 23 new retail accounts, including Vibes and High Times. NutraNomics aims to grow its retail customer base to over 300 by the year's end, leveraging its strategic position for increased sales.
NutraNomics, Inc. (OTC PINK:NNRX) reported record sales bookings for August 2022, achieving $505,463 compared to an average of $335,000 per month. This marks the highest single-month new sales production in the company's history. The strategy focused on diversifying the customer base and strengthening relationships led to 9 new customer logos being secured, expected to drive reorder revenue in September. With Q3 sales matching the highest revenue quarter ever, the company anticipates this quarter to be a record.
NutraNomics, Inc. (OTC PINK:NNRX) announced an important production milestone as its subsidiary, The Plant, has manufactured 765,974 units of cannabis-based products since January 1, 2022. The company anticipates exceeding 1.15 million units by the end of 2022, driven by strong sales in Vape Cartridge and Concentrates. Significant advancements in new product development and hiring high-level sales talent are also underway. These efforts are designed to enhance NutraNomics' market presence and production capacity for future growth.
FAQ
What is the market cap of NUTRANOMICS (NNRX)?
